UBS analysts have predicted that investors would react positively should London-listed (re)insurer Amlin exercise an option to buy out its joint venture partners in ILS fund manager Leadenhall Capital Partners in 2014.
UBS analysts have predicted that investors would react positively should London-listed (re)insurer Amlin exercise an option to buy out its joint venture partners in ILS fund manager Leadenhall Capital Partners in 2014.